摘要
炎症小体的研究主要集中在神经组织,特别是受损组织。目前大多数神经学文献都涉及到利用星形胶质细胞的体内和体外研究,因为星形胶质细胞表达细胞骨架胶质纤维酸性蛋白(GFAP),这是神经病理学疾病的标志。研究表明,星形胶质细胞通过反应性星形胶质增生对所有形式的神经损伤或疾病都有反应。此外,科学家们一致认为炎症小体在神经炎症中发挥着重要作用。本文综述了炎性小体生物学的最新进展,描述了目前对炎性小体如何在大脑中触发的理解,并总结了炎性小体NLR在流行神经系统疾病中的相关性的文献。
关键词: 星形胶质细胞、炎性小体、神经系统疾病、炎症、信号传导、NOD-样受体。
Current Medicinal Chemistry
Title:Astrocytes and Inflammasome: A Possible Crosstalk in Neurological Diseases
Volume: 28 Issue: 24
关键词: 星形胶质细胞、炎性小体、神经系统疾病、炎症、信号传导、NOD-样受体。
摘要: Inflammasome research has primarily focused on neurological tissue, particularly on damaged tissue. Most current neurological literature involves in vivo and in vitro studies utilizing astroglia, as astroglia express the cytoskeletal glial fibrillary acidic protein (GFAP), which is used as a hallmark of neuropathological disorders. Research suggests that astrocytes respond to all forms of neurological damage or disease through reactive astrogliosis. Additionally, there is a consensus among scientists that inflammasomes play an important role in neuroinflammation. This review focuses on the latest developments in inflammasome biology, describing the current understanding of how inflammasomes can be triggered in the brain and summarizing the literature on the relevance of inflammasome NLR in prevalent neurological diseases.
Export Options
About this article
Cite this article as:
Astrocytes and Inflammasome: A Possible Crosstalk in Neurological Diseases, Current Medicinal Chemistry 2021; 28 (24) . https://dx.doi.org/10.2174/0929867328666210301105422
DOI https://dx.doi.org/10.2174/0929867328666210301105422 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in Peptide-Based Approaches for Cancer Treatment
Current Medicinal Chemistry Drug Targeting to the Brain - A Review
Current Nanoscience Potential of Selected Antioxidants for Influenza Chemotherapy
Anti-Infective Agents in Medicinal Chemistry Brain Delivery Systems via Mechanism Independent of Receptor-Mediated Endocytosis and Adsorptive-Mediated Endocytosis
Current Pharmaceutical Biotechnology Syphilis: An Epidemiological Review
Current Women`s Health Reviews Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision
Anti-Cancer Agents in Medicinal Chemistry A Review of Epidemic Models Related to Meteorological Factors
Current Bioinformatics Sepsis Pathophysiology and Anesthetic Consideration
Cardiovascular & Hematological Disorders-Drug Targets Recent Developments in the Synthesis and Biological Activity of Muramylpeptides
Current Medicinal Chemistry The Emergence of Quaternary Ammonium Compounds Resistance in Escherichia coli Isolated from Hospitals of Qazvin, Iran
Infectious Disorders - Drug Targets Vasculogenic and Angiogenic Pathways in Moyamoya Disease
Current Medicinal Chemistry Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based Treatment
Current Pharmaceutical Design Novel Therapeutic Agents for Resistant Gram-Positive Infections
Current Drug Therapy Cannabinoids as Neuroprotective Agents in Traumatic Brain Injury
Current Pharmaceutical Design Phosphodiesterase as a New Therapeutic Target for the Treatment of Spinal Cord Injury and Neurodegenerative Diseases
Current Medicinal Chemistry Hybrid Drugs as Potential Combatants Against Drug-Resistant Microbes: A Review
Current Topics in Medicinal Chemistry Small Molecule Hydrazide Agents to Inhibit Growth and Proliferation of Mycobacterium Tuberculosis
Medicinal Chemistry Immunotherapeutic Approaches in MS: Update on Pathophysiology and Emerging Agents or Strategies 2006
Endocrine, Metabolic & Immune Disorders - Drug Targets Intrathecal Enzyme Replacement Therapy for Mucopolysaccharidosis I: Translating Success in Animal Models to Patients
Current Pharmaceutical Biotechnology Pharmacokinetics of Topical Ocular Drug Delivery: Potential Uses for the Treatment of Diseases of the Posterior Segment and Beyond
Current Drug Metabolism